INCY:NASDAQ
Incyte Corp
$113.44
arrow_upward
+0.63%(+0.71) 1D
$111.97
arrow_downward
-1.30% (-1.47)bedtimeAfter hours
Closed: Oct 7, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$112.82
High
$115.49
Low
$112.46
Mkt. cap
22.99B
Avg. vol.
1.55M
Volume
0.00
P/E ratio
14.46
52-wk high
$132.58
52-wk low
$82.82
EPS
$7.85
Beta
0.74
Shares outstanding
202.70M
No. of employees
3K
Open
$112.82
High
$115.49
Low
$112.46
Mkt. cap
22.99B
Avg. vol.
1.55M
Volume
0.00
P/E ratio
14.46
52-wk high
$132.58
52-wk low
$82.82
EPS
$7.85
Beta
0.74
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
Simply Wall Street
·
6 hours ago
Incyte (INCY) Won New Approvals, Is The Pullback A Cheap Entry?
Benzinga
·
7 hours ago
If You Invested $1000 In Incyte Stock 15 Years Ago, You Would Have This Much Today
AD HOC NEWS
·
1 day ago
Stifel raises target for Incyte stock to USD 157
News Corp
·
1 day ago
Incyte Corp. stock underperforms Tuesday when compared to competitors
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com